Search research articles
Contact Us
Filters
Showing results (51-60 of 122) with videos related to
Page
of 13
Sort By:
Anti-Cancer Drug Design
|
January 1, 1997
S-2-amino-5-(2-nitroimidazol-1-yl)pentanoic acid: a model for potential bioreductively activated prodrugs for inhibitors of nitric oxide synthase (NOS) activity
S Ulhaq, M A Naylor, E C Chinje, et al.
Future Medicinal Chemistry
|
July 2, 2024
Thiourea-functionalized aminoglutethimide derivatives as anti-leishmanial agents
Muhammad Sajid, Hina Siddiqui, Humaira Zafar, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Design and Discovery of 2-Arylquinazolin-4-ones as Potent and Selective Inhibitors of Tankyrases
Amit Nathubhai, Pauline J Wood, Matthew D Lloyd, et al.
Chemical Communications (Cambridge, England)
|
October 4, 2014
The perils of rational design--unexpected irreversible elimination of fluoride from 3-fluoro-2-methylacyl-CoA esters catalysed by α-methylacyl-CoA racemase (AMACR; P504S)
Maksims Yevglevskis, Guat L Lee, Michael D Threadgill, et al.
Bioorganic & Medicinal Chemistry
|
April 25, 2007
Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis
Mervat H R I El-Hamamsy, Anthony W Smith, Andrew S Thompson, et al.
Bioorganic & Medicinal Chemistry
|
September 3, 2003
Synthesis of N-benzyl- and N-phenyl-2-amino-4,5-dihydrothiazoles and thioureas and evaluation as modulators of the isoforms of nitric oxide synthase
Claire L M Goodyer, Edwin C Chinje, Mohammed Jaffar, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
|
April 21, 2011
Cloning, purification, crystallization and preliminary crystallographic analysis of the human histone deacetylase sirtuin 1
Kenneth P Holbourn, Matthew D Lloyd, Andrew S Thompson, et al.
Anti-Cancer Drug Design
|
October 1, 1992
Synthesis and biological evaluation of a series of flavones designed as inhibitors of protein tyrosine kinases
B D Cunningham, M D Threadgill, P W Groundwater, et al.
Biomedical Mass Spectrometry
|
August 1, 1983
Metabolism of the anticancer agent 1-(4-acetylphenyl)-3,3-dimethyltriazene
P Farina, E Benfenati, R Reginato, et al.
Journal of Economic Entomology
|
June 1, 1971
Drift of methyl parathion aerially applied low volume and ultra low volume
H M Adair, F A Harris, M V Kennedy, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 122) with videos related to
Sort By:
Page
of 13
Anti-Cancer Drug Design
|
January 1, 1997
S-2-amino-5-(2-nitroimidazol-1-yl)pentanoic acid: a model for potential bioreductively activated prodrugs for inhibitors of nitric oxide synthase (NOS) activity
S Ulhaq, M A Naylor, E C Chinje, et al.
Future Medicinal Chemistry
|
July 2, 2024
Thiourea-functionalized aminoglutethimide derivatives as anti-leishmanial agents
Muhammad Sajid, Hina Siddiqui, Humaira Zafar, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Design and Discovery of 2-Arylquinazolin-4-ones as Potent and Selective Inhibitors of Tankyrases
Amit Nathubhai, Pauline J Wood, Matthew D Lloyd, et al.
Chemical Communications (Cambridge, England)
|
October 4, 2014
The perils of rational design--unexpected irreversible elimination of fluoride from 3-fluoro-2-methylacyl-CoA esters catalysed by α-methylacyl-CoA racemase (AMACR; P504S)
Maksims Yevglevskis, Guat L Lee, Michael D Threadgill, et al.
Bioorganic & Medicinal Chemistry
|
April 25, 2007
Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis
Mervat H R I El-Hamamsy, Anthony W Smith, Andrew S Thompson, et al.
Bioorganic & Medicinal Chemistry
|
September 3, 2003
Synthesis of N-benzyl- and N-phenyl-2-amino-4,5-dihydrothiazoles and thioureas and evaluation as modulators of the isoforms of nitric oxide synthase
Claire L M Goodyer, Edwin C Chinje, Mohammed Jaffar, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
|
April 21, 2011
Cloning, purification, crystallization and preliminary crystallographic analysis of the human histone deacetylase sirtuin 1
Kenneth P Holbourn, Matthew D Lloyd, Andrew S Thompson, et al.
Anti-Cancer Drug Design
|
October 1, 1992
Synthesis and biological evaluation of a series of flavones designed as inhibitors of protein tyrosine kinases
B D Cunningham, M D Threadgill, P W Groundwater, et al.
Biomedical Mass Spectrometry
|
August 1, 1983
Metabolism of the anticancer agent 1-(4-acetylphenyl)-3,3-dimethyltriazene
P Farina, E Benfenati, R Reginato, et al.
Journal of Economic Entomology
|
June 1, 1971
Drift of methyl parathion aerially applied low volume and ultra low volume
H M Adair, F A Harris, M V Kennedy, et al.
Page
of 13